Fig. 7From: Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsetsThe schematic diagram illustrates the role of SOD2 in the regulation of TIC features in TMZ-resistant GBM cells. When SOD2 is down-regulated in cells with TIC features following TMZ treatment, cell apoptosis is enhanced and some TIC properties are impairedBack to article page